Dr. Steven Regwan, DO

Dr. Regwan practices at Salinas Valley Memorial Hospital - Cardiac Diagnostic Imaging Center - HOPD in Salinas, California.

Dr. Regwan's NPI, 1952525123, was assigned on April 12, 2007. Dr. Regwan graduated from Arizona College of Osteopathic Medicine - Glendale in 2005. Dr. Regwan holds California license 20A14198.

Dr. Regwan's primary practice is Salinas Valley Memorial Hospital - Cardiac Diagnostic Imaging Center - HOPD, at 230 San Jose Street, Salinas, CA 93901.

Dr. Regwan's primary practice is Salinas Valley Memorial Hospital - Cardiac Diagnostic Imaging Center - HOPD in Salinas, California. Dr. Regwan is also affiliated with Salinas Valley Health Medical Center. The medical group on file is Salinas Valley Health Clinics. Dmand AI also links Dr. Regwan to 3 more hospitals, 7 medical groups and 4 group practices and clinics, each named with a free account. Dr. Regwan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Regwan practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Regwan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Regwan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Regwan's licenses on file in 2 states: California and Nevada.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and coronary artery disease among the conditions Dr. Regwan treats.

CMS data shows 5,882 Medicare services from Dr. Regwan across 39 procedure codes in 2024, for 2,049 Medicare patients. Medicare paid $262,956 for them.

CMS counts 2,049 Medicare patients who saw Dr. Regwan in 2024. The largest group is 75 to 84, with 775 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Regwan's median patient age at 60, with 56% women.

In 2024, Dr. Regwan wrote 2,887 Medicare Part D claims for 430 patients. 81% of them were for generic drugs. CMS names the drug for 2,614 of them, across 36 drugs with 11 or more claims each, at $535,324 in total drug cost. In 2023, CMS named 2,474 claims across 37 drugs.

Dr. Regwan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of pacemaker insertion or repair by Dr. Regwan, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Regwan. Dr. Regwan's most frequent co-authors are Edward Anthony Hulten, MD, MPH, Shaun Andrew Martinho, DO and Joshua Delbert Mitchell, MD.

CMS Open Payments shows 1,713 general payments to Dr. Regwan from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Relypsa, Inc. paid the most, $164,773.

Dmand AI lists 1 award for Dr. Regwan.

Dr. Regwan graduated from Arizona College of Osteopathic Medicine - Glendale in 2005. Dr. Regwan is a member of ACC.

Dr. Regwan is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.